/C O R R E C T I O N - Pierre Fabre Pharmaceuticals/

Barchart · 2d ago

The BLA has a Prescription Drug User Fee Act target action date of March 31, 2027

Accepted resubmission includes an updated dataset with additional patients and longer follow-up from the Phase 3 single-arm ALLELE study, as well as expansive supplemental data

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.